Chicago, IL (April 27, 2006)—In an effort to provide women suffering from gynecologic cancer with the most up-to-date and easy-to-understand information on available clinical trials, the Gynecologic Cancer Foundation (GCF) and the Gynecologic Oncology Group (GOG) have joined together to make information about GOG Phase III clinical trials available on the Web.
The new GOG Clinical Trials page, on GCF’s award-winning Women’s Cancer Network, www.wcn.org, provides women and their families with information on how to enroll in each trial. Each section also provides a detailed description of the trial, including the purpose of the study, how it works, eligibility requirements and potential risks and benefits.
Women who feel they are eligible for a particular trial can call GOG headquarters where specially trained staff will help determine the nearest participating clinical site and provide the name and telephone number for the individual responsible for enrollment.
“It is our hope that GCF’s partnership with the GOG will allow for easier dissemination of clinical trial information, and will encourage gynecologic cancer patients to enroll in upcoming trials,” stated GCF Chair, Dr. Karl Podratz, MD, PhD. “I would like to thank the GOG for their generous contribution for this worthy endeavor.”
“The GOG is committed to promoting excellence in research in the gynecologic oncology field,” states GOG Chair, Dr. Philip DiSaia, MD. “Working with GCF to promote clinical trial enrollment allows us to reach more women interested in trial participation and in turn, complete valuable research studies in a more timely fashion.”
For more information about the Women’s Cancer Network or GOG Clinical Trials, visit www.wcn.org.
About the Gynecologic Cancer Foundation
The Gynecologic Cancer Foundation is a not-for-profit charitable organization established by the Society of Gynecologic Oncologists in 1991 to support research related to gynecologic cancers, to fund training of clinician scientists, and to increase public awareness and information related to gynecologic cancers and their precursors. The mission of the Gynecologic Cancer Foundation (GCF) is to ensure public awareness of gynecologic cancer prevention, early diagnosis and proper treatment. GCF advances this mission by increasing public and private funds that aid in the development and implementation of programs to meet these goals. GCF was named by Worth Magazine as one of “America’s 100 Best Charities.” Of the 26 health organizations listed, GCF was one of only two organizations solely focused on women’s health. For more information, please visit www.thegcf.org or call 800.444.4441.